About
Technology
Issues
FAQ
Links
Official Page
RETRACTED ARTICLE: Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.